Jin-Bo Li

Progress of siRNA Nanomedicines in Modulating the Microenvironment of Triple-Negative Breast Cancer

Abstract Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, and its poor prognosis, chemoresistance, and limited immunotherapy response are closely linked to pathological remodeling of the tumor microenvironment (TME). Targeting the TME has emerged as a promising strategy, but convention...